Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2

J Infect. 2022 Oct;85(4):e104-e108. doi: 10.1016/j.jinf.2022.06.033. Epub 2022 Jul 5.
No abstract available

Keywords: BA.2; Omicron; SARS-CoV-2; Sotrovimab.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antibodies, Neutralizing
  • COVID-19*
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • sotrovimab